Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits

Background: The coronavirus disease 2019 (COVID-19) pandemic forced healthcare systems to rethink healthcare delivery, and forced primary care pharmacists in our healthcare system to switch all visits that were previously face to face (FTF) to telehealth. Methods: We conducted a retrospective observ...

Full description

Bibliographic Details
Main Authors:	Lee, S.-Y (Author), McNamara, A. (Author), Zhao, M. (Author)
Format:	Article
Language:	English
Published:	John Wiley and Sons Inc 2021
Subjects:	acquired immune deficiency syndrome adult African American aged Alaska Native American Indian antibiotic agent anticoagulant agent antineoplastic agent Article Asian blood pressure regulation Caucasian cerebrovascular accident Charlson Comorbidity Index chronic kidney failure chronic obstructive lung disease clinical pharmacist cohort analysis congestive heart failure connective tissue disease controlled study coronavirus disease 2019 COVID-19 dementia diabetes mellitus female follow up health care system heart infarction hemiplegia hemoglobin A1c Hispanic homelessness hospitalization human insulin leukemia liver disease lymphoma major clinical study male narcotic analgesic agent Native Hawaiian neuroleptic agent observational study Pacific Islander peptic ulcer peripheral vascular disease pharmacist primary medical care retrospective study solid malignant neoplasm telehealth transient ischemic attack
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits

Internet

Similar Items